Review
Developments in preclinical AIDS vaccine efficacy models
Affiliations
- PMID: 11086857
Item in Clipboard
Review
Developments in preclinical AIDS vaccine efficacy models
AIDS.
2000.
No abstract available
Similar articles
-
Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).Virology. 2001 Jan 5;279(1):241-56. doi: 10.1006/viro.2000.0695. Virology. 2001. PMID: 11145906
-
Feline immunodeficiency virus as a model for AIDS vaccination.AIDS. 1990;4 Suppl 1:S163-5. AIDS. 1990. PMID: 1967108 Review. No abstract available.
-
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005. J Virol. 2005. PMID: 16160159 Free PMC article.
-
HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.Science. 2004 Jun 4;304(5676):1437. doi: 10.1126/science.304.5676.1437. Science. 2004. PMID: 15178780 No abstract available.
-
Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.AIDS. 2007 Mar 12;21(5):547-63. doi: 10.1097/QAD.0b013e328013d88a. AIDS. 2007. PMID: 17314517 Review. No abstract available.
Cited by
-
Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.J Virol. 2002 Oct;76(20):10299-306. doi: 10.1128/jvi.76.20.10299-10306.2002. J Virol. 2002. PMID: 12239306 Free PMC article.
-
V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.J Virol. 2005 Oct;79(19):12296-303. doi: 10.1128/JVI.79.19.12296-12303.2005. J Virol. 2005. PMID: 16160156 Free PMC article.
-
A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.J Virol. 2003 Jul;77(13):7244-53. doi: 10.1128/jvi.77.13.7244-7253.2003. J Virol. 2003. PMID: 12805423 Free PMC article.
-
Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.Vaccine. 2010 Nov 29;28(51):8095-104. doi: 10.1016/j.vaccine.2010.10.003. Epub 2010 Oct 16. Vaccine. 2010. PMID: 20955830 Free PMC article.
-
Envelope variation as a primary determinant of lentiviral vaccine efficacy.Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15105-10. doi: 10.1073/pnas.0706449104. Epub 2007 Sep 10. Proc Natl Acad Sci U S A. 2007. PMID: 17846425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical